Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Brent Lawrence

Orthopaedic Surgery Conway, AR Medical Doctor

NPI 1992966295 CMS profile 90480

800 Exchange Ave Ste 102B, Conway, AR 72032

Open in the dashboard

General payments

$13,995

217 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Brent Lawrence of Conway, AR is reported in the CMS Open Payments database as having received $13,995 across 217 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 75th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,690 34
2024 General $2,813 39
2023 General $2,352 33
2022 General $1,876 38
2021 General $2,812 50
2020 General $571 15
2019 General $1,881 8

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brent Lawrence
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Brent Lawrence were reported at $1,690. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Brent Lawrence Orthopaedic Surgery median Middle half National median
2019 $1,881 $644 $140–$2,844 $163
2020 $571 $312 $75–$1,860 $114
2021 $2,812 $520 $117–$2,495 $132
2022 $1,876 $598 $128–$2,731 $149
2023 $2,352 $461 $128–$2,264 $160
2024 $2,813 $497 $134–$2,475 $164
2025 $1,690 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $6,450 58 payments
  2. Zimmer Biomet Holdings, Inc. $2,106 12 payments
  3. Midsouth Orthopedics $1,565 2 payments
  4. Horizon Therapeutics plc $585 41 payments
  5. Radius Health, Inc. $568 22 payments
  6. Amgen Inc. $407 21 payments
  7. Smith+Nephew, Inc. $375 7 payments
  8. Kerecis Limited $327 3 payments
  9. Heron Therapeutics, Inc. $264 4 payments
  10. Vertex Pharmaceuticals Incorporated $159 3 payments
  11. Other $1,189 44 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $10,872 209 payments
  2. Education $1,915 2 payments
  3. Travel and Lodging $1,208 6 payments
Products named General payments · program years 2019–2025
  1. MAKO Knees, Hips $1,780 17 payments
  2. MAKO Joint Replacement Hips, Knees $1,352 11 payments
  3. ROSA-Knee $1,248 7 payments
  4. AXSOS $1,157 10 payments
  5. Tymlos $421 14 payments
  6. EVENITY $407 21 payments
  7. Taperloc $364 1 payment
  8. Persona $364 1 payment
  9. PENNSAID $353 33 payments
  10. PANGEA $321 2 payments
  11. Other $7,633 141 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 16 drugs

Part D claims

744

Median for Orthopedic Surgery: 203

Drug cost

$18,893

Median for Orthopedic Surgery: $1,433

Branded share of claims

39.7%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 21 $9,423
Vancomycin Hcl Generic 11 $2,495
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 222 $1,964
Mupirocin Generic 85 $734
Ibuprofen Generic 71 $669
Cefdinir Generic 54 $667
Celecoxib Generic 21 $630
Cefazolin Sodium Generic 11 $471
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 52 $461
Cephalexin Generic 23 $384

The 10 drugs with the highest cost, of 16 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 102 billing codes

Paid by Medicare

$139,582

Of which drugs: $6,622

Medicare patients

302

Average age 74

Services billed

2,449

186 women, 116 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 74%
Ischemic heart disease 33%
Depression 32%
Diabetes 29%
COPD 25%
Atrial fibrillation 23%
Heart failure 21%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg J7318 Office 12 1,020 $5,219
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 46 204 $146

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

3 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Tymlos
  • Radius Health, Inc. $177
$177 — —
EVENITY
  • Amgen Inc. $145
$145 — —
Prolia
  • Amgen Inc. $64
$64 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

217 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Arkansas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record